While there is considerable evidence to suggest that the inhibition of RyRs might protect neuronal function during AD, much remains to be done, especially in the understanding of the mechanisms induced by RyR dysfunctions that lead to alterations in synaptic properties and the intrinsic excitability of central neurons during AD onset. Here, RYR1 is linked to Alzheimer disease.